TSC1 and TSC2 are responsible for the tumor suppressor gene syndrome tuberous sclerosis (TSC). Mammalian TSC genes have been shown to be involved in cell cycle regulation. Recently, in Drosophila, these data have been confirmed and TSC genes have further been demonstrated to affect cell size control. Here we provide supporting data for the fact that the latter function is conserved in mammals. Human TSC1 and TSC2 trigger mammalian cell size reduction and a dominant-negative TSC2 mutant induces increased size. These effects occur in all cell cycle phases, are dependent on the activity of the phosphoinositide-3-kinase and are abolished by co-overexpression of a dominant-negative Akt mutant. Two independent naturally occurring and disease-causing mutations within the TSC2 gene eliminate tuberin's capacity to affect cell size control, emphasizing the relevance of this function for the development of the disease. The same mutations have earlier been shown not to affect tuberin's antiproliferative capacity. That the consequences of modulated TSC gene expression on cell proliferation and on cell size can be assigned to separable functions is further supported by two findings: A mutation within the TSC1 gene, earlier shown to still harbor anti-proliferative effects, was found to eliminate the cell size regulating functions. An important mammalian cell size regulator, c-Myc, was found to inhibit tuberin's antiproliferative capacity, but to have no effects on tuberin-dependent cell size control. To obtain further mechanistical insights, microarray screens for genes involved in TSC1-or TSC2-mediated cell size effects were performed. Antisense experiments revealed
Introduction
Tuberous sclerosis (TSC) is an autosomal dominant disease occurring in about 1 in 6000 live births. It is characterized by mental retardation, epilepsy and by the development of tumor-like growths, such as benign cortical tubers and other lesions, all named hamartomas, affecting the kidneys, heart, lung and skin (Gomez et al., 1999; Cheadle et al., 2000) . TSC1 on chromosome 9q34 encodes a 130 kDa protein named hamartin (The TSC1 Consortium, 1997) and TSC2 on chromosome 16p13.3 encodes a 200 kDa protein, named tuberin (The European Chromosome 16 Tuberous Sclerosis Consortium, 1993) .
TSC1 and TSC2 null mice die at mid-gestation (Kobayashi et al., 1999 (Kobayashi et al., , 2001 Onda et al., 1999; Kwiatkowski et al., 2002) . The variety of different described functions for tuberin include a GAP activity for Rap1a (Wienecke et al., 1995) and for Rab5 (Xiao et al., 1997) , and involvement in transcriptional control Henry et al., 1998; Lou et al., 2001) , in the regulation of neuronal differentiation (Soucek et al., 1998a) , in the functional localization of polycystin-1 (Kleymenova et al., 2001) and in the regulation of b-catenin signaling activity (Mak et al., 2003) . Hamartin binds ezrin/radixin/moesin protein family members and regulates Rho GTPases (Lamb et al., 2000) . Mammalian hamartin and tuberin associate physically in vivo (Plank et al., 1998; Van Slegtenhorst et al., 1998; Nellist et al., 1999) , suggesting that these two proteins function in the same complex. This interaction is regulated by tuberin phosphorylation (Aicher et al., 2001 ) and prevents tuberin ubiquitination (Benvenuto et al., 2000) .
Their postulated tumor suppressor function made it tempting to speculate that loss of functional TSC1 or TSC2 can induce uncontrolled proliferation. First experimental confirmation of this hypothesis was provided by the observation that antisense inhibition of TSC2 expression induced quiescent Rat1 fibroblasts to enter the cell cycle (Soucek et al., 1997) . That TSC2-negative cells exhibit an increased proliferation rate compared to their TSC2-positive counterparts has further been shown on analysing fibroblasts homozygous for a TSC2-mutation derived from Eker rat embryos (Soucek et al., 1998b) . A common approach to investigate a putative function of tumor suppressor genes in proliferation control is to analyse their ability, when ectopically overexpressed in cells, to inhibit cell proliferation. These effects have been shown to be mediated via ectopic TSC2 (Jin et al., 1996; Orimoto et al., 1996) and via TSC1 (Benvenuto et al., 2000; Miloloza et al., 2000) . Both TSC gene products regulate the expression of the cyclin-dependent kinase inhibitor p27, a well-known cell cycle regulator (Soucek et al., 1998b; Miloloza et al., 2000) . Identification of TSC gene homologs allowed confirmation of their effects on proliferation control in Drosophila (Ito and Rubin, 1999; Gao and Pan, 2001; Potter et al., 2001; Tapon et al., 2001) .
Clonal expansion of transformed cells as they form a tumor is dependent on an increase in cell cycle progression (cell proliferation) and in cell size (cell growth). These two processes are co-ordinated since initiation of DNA replication does not occur until cells reach a minimum size. In yeast, this control acts at a point in G1 phase, called START, and in mammals commitment to DNA replication is also thought to occur at a point in G1, termed the restriction point (Pardee, 1974; Nurse, 1975; Zetterberg et al., 1995) . However, so far only few genes have been implicated in mammalian cell size regulation (Stocker and Hafen, 2000; Prober and Edgar, 2001) , including the transcription factor c-Myc (Iritani and Eisenman, 1999; Schuhmacher et al., 1999) . Interestingly, Myc's effects on cell size control are independent of its influence on the cell cycle via regulation of kinases Beier et al., 2000) . In contrast, data from knock-out models demonstrated that c-Myc regulates mammalian body size by controlling cell number but not cell size (Trumpp et al., 2001) , emphasizing the importance of further investigation.
Major insights into the control of cell size have been provided by studies in Drosophila (Montagne et al., 2001) . Recently, analyses of the Drosophila homologs revealed a new important function for TSC genes: Cells mutant for TSC1 or TSC2 are increased in cell size. Organ size is also increased in tissues that contain a majority of mutant cells. The reported data are consistent with a model indicating that the Drosophila TSC genes function together in the insulin signaling pathway (Ito and Rubin, 1999; Gao and Pan, 2001; Potter et al., 2001; Tapon et al., 2001) . To date, more data have accumulated demonstrating that Drosophila and mammalian TSC genes are involved in the regulation of the insulin signaling pathway. In this pathway, following binding of IGF molecules to their receptors, a signal is relayed via lipid and protein kinases that increases the translation rate of RNAs specifically regulated via the translation initiation factor eIF4E and additionally results in phosphorylation of the 40S ribosomal protein S6 by S6kinase (S6K) and increased translation rates of specific messages, mainly from genes involved in ribosome biogenesis. This cascade includes the phosphoinositide-3-kinase (PI3K), 3-phosphoinositide-dependent protein kinase (PDK1), Akt kinase and the FKBP12-rapamycin-associated protein mTOR and affects cell proliferation and cell size regulation. Evidence has been provided that tuberin is phosphorylated by Akt, and that the tuberin/hamartin complex negatively regulates the activities of mTOR and S6K (Kwiatkwoski et al., 2002; Gao et al., 2002; Goncharova et al., 2002; Inoki et al., 2002; Jaeschke et al., 2002; Manning et al., 2002; Potter et al., 2002; Radimerski et al., 2002; Tee et al., 2002) . The PTEN tumor suppressor gene is a lipid phosphatase that negatively regulates cell survival mediated by the PI3K/Akt signaling pathway. Recent in vivo studies demonstrated a role for PTEN in the size control of neurons, although other studies revealed that PTEN-null fibroblasts do not display any apparent defects in cell size (reviewed in Backman et al., 2002; Kwan, 2002) .
We investigated whether human TSC genes also harbor cell size regulating functions, whether natural occurring disease causing mutations eliminate these properties and whether such a function would depend on the activity of PI3K or Akt. Furthermore, we investigated the functional interaction of TSC genes and c-Myc in regulating cell cycle and cell size control in mammals. To obtain more and new mechanistic evidence as to how TSC1 and TSC2 alter cell size regulation, microarray screens were performed and FKBP38 was identified to be important for TSC genemediated effects.
Results
Human TSC1 affects cell size regulation independent of the cell cycle phase Logarithmically growing HeLa cells were cotransfected with a mammalian expression vector harboring fulllength human TSC1 and a green fluorescence protein (GFP)-expressing vector. Forward scatter (FSC) analyses of GFP-gated cells demonstrated a reduction in cell size upon TSC1 overexpression (Figure 1a-c) . These data have been confirmed by repeating a set of such experiments under the same conditions described in Figure 5 (see Figure 5c without LY294002). The P-value for the difference in cell size between empty vector control and TSC1 overexpressors is P ¼ 0.000004. To investigate whether this reduction occurs in a cell cycle phase-dependent manner cellular DNA was stained and two-dimensional contour blot analyses of FSC versus DNA content were performed. The TSC1-induced cell size reduction was observed in G1 cells and in G2/M cells with doubled DNA content (Figure 1d ). Hamartin harbors a transmembrane domain at amino acids 127-144 (The TSC1 Consortium, 1997), a domain necessary for the regulation of Rho at amino acids 145-510 (Lamb et al., 2000) , a predicted coiled-coil structure spanning amino acids 719-998 (The TSC1 Consortium, 1997) and the domain at amino acids 881-1084 involved in binding to ERM proteins (Lamb et al., 2000) . Using the same experimental approach, we investigated the effects on cell size regulation of the TSC1 mutant 127 containing amino acids 788-1153 cloned behind an N-terminal Xpress epitope tag. This mutant neither encodes the transmembrane domain nor the Rho regulating domain, harbors most of the coiled-coil region and encodes the region involved in binding to ERM. We found this mutant to have no effects on mammalian cell size regulation (Figure 1 ). This control experiment also confirms that overexpression approaches as performed in this study are suitable to test TSC genes for their capacity to control cell size. These results demonstrate that human TSC1 regulates cell size independent of the cell cycle phase.
Wild-type human TSC2, but not naturally occurring TSC2 mutants, triggers cell size reduction FSC analysis of GFP-gated cells revealed that overexpression of full-length human TSC2 triggers a cell size reduction of HeLa cells (Figure 2a-c ) independent of the cell cycle phase (Figure 2d ). These data have been confirmed by repeating a set of such experiments under the same conditions described in Figure 5 (see Figure 5c without LY294002). The P-value for the difference in cell size between the empty vector control and TSC2 overexpressors is P ¼ 0.00347. Tuberin has been proposed to harbor a leucin zipper region at amino acids 75-107, coiled-coil structures at amino acids 346-371 and 1008-1021, a rap1GAP and a rabaptin-binding domain at amino acids 1668-1726 (The European Chromosome 16 Tuberous Sclerosis Consortium, 1993; Maheshwar et al., 1997; Xiao et al., 1997) . Tuberin possesses GAP activity for the GTPase Rap1a (Wienecke et al., 1995) and mutation analysis of the rap1GAP-related domain in TSC patients led to the characterization of disease-associated mutations including missense mutations that were shown to occur as de novo mutations in sporadic TSC cases (Maheshwar et al., 1997) . Two of such reported mutations, TSC2 6 2/25 and TSC2 6 3/5, were tested for their capacity to regulate cell size. Both naturally occurring mutations eliminated the effects of TSC2 on cell size (Figure 2) .
We further wanted to investigate whether cells lacking functional tuberin, such as the cells that give rise to the lesions of TSC patients, may also exhibit deregulated cell size control. Overexpression of the dominantnegative mutant TSC2DRL, lacking the rabaptin-5 binding domain and leucine zipper motifs of tuberin, was shown to downregulate functions and cellular effects known to be associated with tuberin. Ectopic expression of this mutant has been demonstrated to increase endocytosis and to cause a shift of the cyclindependent kinase inhibitor p27 from the nucleus to the cytoplasm accompanied by downregulation of p27 expression. That cells expressing this mutant proliferate more rapidly has already repeatedly been proven in the past in long-term proliferation assays (Pasumarthi et al., 2000) and in short-term experiments (Miloloza et al., 2002) . To once again confirm this activity of the mutant in HeLa cells, cotransfection experiments with TSC2DRL and GFP-expressing vectors were performed. DNA distribution analyses of GFP-gated cells confirmed the capacity of this mutant to induce cell proliferation as detected by a decrease of G1 cells and an increased S phase amount (Figure 3a , b). FSC TSC1-and TSC2-mediated effects on cell size are dependent on PI3K and Akt As described in the introduction, hamartin and tuberin have recently been found to be involved in the regulation of the insulin signaling pathway. Accordingly, we wondered whether the effects of these two tumor suppressor proteins on cell size regulation depend on the activity of PI3K. LY294002 is a pharmacological drug inhibitor of PI3K. Since PI3K phosphorylates Akt, the inhibition of PI3K activity via LY294002 can be monitored by analysing the amount of phosphorylated Akt . By Western blot analyses using the Antiphospho-Akt Antibody #9271 from Cell Signaling Technology, we demonstrated the inhibitory activity of LY294002 also in cells with overexpressed TSC1 or TSC2 (Figure 5a ). FSC analyses revealed that in LY294002-treated cells, ectopically overexpressed TSC genes lost their capacity to downregulate cell size (Figure 5b, c) . These data demonstrate that TSC gene-mediated cell size control depends on the activity of PI3K.
To investigate the role of Akt in the observed effects of TSC genes here, we performed co-overexpressions of the TSC genes with and without a dominant-negative Akt mutant. Cell size analyses on the Casy Cell Counter and Analyser revealed that ectopic TSC1 and TSC2 cannot trigger negative effects on mammalian cell size regulation in cells without functional Akt (Figure 6 ).
Tuberin's effects on proliferation, but not on cell size, are inhibited by c-Myc c-Myc is implicated in the regulation of mammalian cell cycle and cell size control Iritani and Eisenman, 1999; Schuhmacher et al., 1999; Beier et al., 2000; Trumpp et al., 2001) . Recently, a DNA microarray screen revealed upregulation of TSC2 mRNA via c-Myc (Schuldiner and Benvenisty, 2001) . At least in the Figure 4 Long-term effects of TSC genes on cell size. Selectable mammalian expression vectors, empty as negative control or harboring wild-type TSC1 or TSC2 were transfected into logarithmically growing HeLa cells. Starting with equal cell numbers (harvesting and reseeding), transfected cell pools were kept under selection and cell size was determined 4 days after reseeding, using a Casy Cell Counter and Analyser. Cell size is given in percentage relative to the control, set as 100% (7standard deviations). The numbers given within the bars (with gray background) represent mean absolute values of the cell size given in femtoliter
Figure 5 TSC1-and TSC2-mediated effects on cell size are dependent on PI3K activity. (a) Mammalian expression vectors, empty as negative control or harboring full-length human TSC1 or TSC2 cDNA, were transfected into logarithmically growing HeLa cells. Cells were cotransfected with a GFP expression vector and treated with (or without) the PI3K inhibitor LY294002 for 24 h before harvest. At 48 h after transfection, the amount of phosphorylated Akt (pAkt Ser473) was determined by Western blot analysis using the Anti-Phospho-Akt Antibody #9271 from Cell Signaling Technology. (b) At 48 h after transfection, the cell size of GFP-gated cells was investigated via FSC analyses on the flow cytometer. (c) Quantitative analysis of the mean FSC of three independent experiments performed as described in (b). Cell size is given in percentage relative to the control, set as 100% (7standard deviations). The given numbers represent the average logarithmically growing Rat1MycER cells used here, we have earlier shown that activation of c-Myc does not influence tuberin protein expression (Soucek et al., 1997) . A lot of explanations for this discrepancy can be assumed and further investigation is warranted. In Drosophila, overexpression of Myc was demonstrated to suppress the effects of ectopic TSC genes on cell size control (Tapon et al., 2001) . Taken together, these findings prompted us to investigate the role of c-Myc for TSC gene-mediated effects on cell cycle and cell size control in mammals. The antiproliferative effects of TSC2 were confirmed by cell counting experiments in Rat1MycER cells kept under selection for ectopic tuberin expression (Figure 7a, b) . The same approach has previously demonstrated that high levels of ectopic TSC1 and TSC2 attenuate cell proliferation/cell cycling (Jin et al., 1996; Orimoto et al., 1996; Soucek et al., 1998b Soucek et al., , 2001 Benvenuto et al., 2000; Miloloza et al., 2000 Miloloza et al., , 2002 . The activation of c-Myc in transfected Rat1MycER cells not only inhibited the antiproliferative effects of tuberin but also cells with high levels of TSC2 and c-Myc exhibited even increased proliferation rates (Figure 7c ). The same experimental approach was used to test for cell size regulation. The results obtained with Rat1MycER cells confirmed the observation in HeLa cells: High levels of TSC2 trigger cell size reduction (Figure 7d ). Interestingly, this regulation was not affected by high levels of c-Myc (Figure 7e) .
A role of FKBP38 in cell size control mediated by the TSC genes
To obtain more mechanistical insights into how TSC genes could mediate their cell size effects we performed In addition, such a microarray approach was of interest because TSC2 has been demonstrated to be involved in transcription control (see Introduction) and no micorarray analysis has been reported so far. HeLa cells were transfected with empty vector controls and vectors harboring TSC1 or TSC2 (as described for Figures 1 and 2) and RNA was extracted 48 h after transfection. Using the MICROMAX Human cDNA System I-Direct, the gene expression pattern in TSC1-overexpressing cells has been compared to empty control vector transfectants. Also, TSC2-overexpressing cells have been compared to empty vector transfectants and each approach has been performed twice in two independent experiments. A summary of all genes (out of the 2400 spotted genes, see www.perkinelmer.com), which were upregulated 4threefold upon overexpression of TSC1 and/or TSC2 is presented in Table 1 . Table 2 presents such a summary for all downregulated genes.
The FK506-binding proteins (FKBPs) are a group of peptidylprolyl cis-trans isomerases (PPIases) known to be involved in the catalysis of protein folding. FKBPs were originally discovered as receptors for the immunosuppressant FK506. Currently, seven FKBPs have been identified in humans playing a role in different regulations, such as cell cycle, cell size and neuroprotective controls (Aghdas et al., 2000; Klettner et al., 2001; Schiene-Fischer and Yu, 2001; Fingar et al., 2002) . This, together with the finding that FKBP38, although expressed in all tissues, occurs with particularly high densities in brain (Lam et al., 1995) , prompted us to further analyse its role in TSC gene-mediated cell size control. Semiquantitative RT-PCR analysis was used to monitor the expression levels of FKBP38 mRNA in the described experimental settings. A 3.4-fold induction of FKBP38 mRNA expression was detectable via semiquantitative RT-PCR in cells with overexpressed wild-type TSC1 (Figure 8a, b) . These data confirmed the findings of the microarray experiments. Further experiments demonstrated that overexpression of the TSC1 mutant 127, which we found as being unable to affect cell size control (Figure 1) , is also unable to trigger upregulation of FKBP38 (Figure 8c ). Overexpression of the dominant-negative mutant TSC2DRL, which we found to cause the opposite effect on cell size control (upregulation of cell size, compare Figure 3 ), also caused a slight opposite effect on FKBP38 expression (downregulation of FKBP38 mRNA, Figure 8d ).
These findings suggested that FKBP38 might play a functional role for TSC gene-mediated cell size effects. Indeed, FSC analyses revealed that in cells treated with FKBP38-specific antisense oligonucleotides, ectopically overexpressed TSC genes lost their capacity to downregulate cell size. It even appeared that in these cells the TSC genes mediated a growth-promoting effect (Figure 9 ). That FKBP38 is involved in mammalian cell size regulation is further suggested by our finding that antisense-treated cells exhibit a 9.8% enlarged cell size compared to control oligonucleotide-treated cells (average of three independent experiments with statistical significance).
Discussion
Recent studies in several model organisms have emphasized the role of oncogenes/tumor suppressor genes in regulating cell size and have suggested that some effects of these genes on the cell cycle may be secondary consequences of growth promotion. In mammals, for example, Ras, Myc, cyclin D, PTEN and/or the insulin signaling pathway have been implicated in cell size (Ito and Rubin, 1999; Gao and Pan, 2001; Potter et al., 2001; Tapon et al., 2001) . To test whether cell size control could be relevant for the development of the disease in patients, it is essential to investigate whether human TSC genes also harbor this property and whether naturally occurring disease-causing mutations eliminate it. Here we demonstrate the human TSC genes, TSC1 and TSC2, to be involved in cell size control. Two independent naturally occurring missense mutations within human TSC2 eliminate tuberin's cell size regulating property. These data suggest that cell size control might be relevant for human TSC development. Additional support for this assumption comes from experiments performed with a dominant-negative TSC mutant known to downregulate tuberin's functions. Overexpression of this mutant causes an increase in cell size suggesting that cells lacking functional tuberin, such as the cells that give rise to the lesions of TSC patients, exhibit such a deregulation. Although cell size regulating properties of TSC homologs are now proven to be conserved between Drosophila and mammals, the data reported here question whether the mechanisms are identical: (1) whereas each mammalian TSC gene alone can affect cell size, in Drosophila, modulated expression of both TSC genes is necessary (Gao and Pan, 2001; Potter et al., 2001; Tapon et al., 2001) . This discrepancy also holds true for the influence of TSC genes on proliferation control (Jin et al., 1996; Orimoto et al., 1996; Soucek et al., 1998b; Ito and Rubin, 1999; Benvenuto et al., 2000; Gao and Pan, 2001; Potter et al., 2001; Soucek et al., 2001; Tapon et al., 2001; Miloloza et al., 2002) . (2) In Drosophila, size reduction upon overexpression of TSC1 and TSC2 was suppressed by overexpression of Myc (Tapon et al., 2001) . We found the cell size effects of human TSC2 as being unaffected by high levels of Myc. These findings highlight the importance of studying the molecular mechanisms involved in TSC genemediated cell size control in parallel in both, Drosophila and mammals. In particular, the question to which extent the cell size effects of the TSC genes depend on the background of the analysed cell type, needs to be further investigated in mammals. Cell type-dependent differences might, for example, provide an explanation for the findings that c-Myc can trigger cell size effects in specific cellular models (Iritani and Eisenman, 1999; Schuhmacher et al., 1999; Beier et al., 2000) , whereas in others it cannot (Trumpp et al., 2001 ). In addition, another important cell size regulator, PTEN, has been shown to control cell size of neurons, although other studies revealed that PTEN-null fibroblasts do not display any apparent defects in cell size (reviewed in Backman et al., 2002; Kwan, 2002) .
Recently, studies in Drosophila and mammals demonstrated that the TSC genes are involved in the regulation of the insulin signaling pathway, which is a very important regulator of cell cycle and cell size control. Evidence has been provided that tuberin is phosphorylated by Akt, and that the tuberin/hamartin complex negatively regulates the activities of mTOR and S6K (Kwiatkwoski et al., 2002; Gao et al., 2002; Goncharova et al., 2002; Inoki et al., 2002; Jaeschke et al., 2002; Manning et al., 2002; Potter et al., 2002; Radimerski et al., 2002; Tee et al., 2002) . In the study presented here, we demonstrate that the TSC gene-mediated effects on cell size are dependent on functional PI3K and Akt. These data suggest that hamartoma cells of TSC patients harbor a deregulated cell size control likely mediated by loss of the proper control of the insulin signaling pathway. In addition, the recent finding that the tuberin/hamartin complex regulates b-catenin signaling activity (Mak et al., 2003) warrants further investigation of whether this signaling cascade is involved in the TSC gene-mediated effects on cell cycle and/or cell size control.
Myc's effects on cell proliferation and cell size control can be assigned to separable functions Iritani and Eisenman, 1999; Schuhmacher et al., 1999; Beier et al., 2000) . Here we report several independent findings suggesting that TSC gene functions in the control of proliferation and cell size are also separable: (1) Two independent disease-causing mutations within the TSC2 gene, earlier shown to influence neither tuberin's antiproliferative capacity nor its effects on p27 expression (Soucek et al., 2001) , have been demonstrated to eliminate the cell size regulating properties. (2) The TSC1 mutant 127, missing hamartin's transmembrane domain and the Rho regulating domain, has earlier been shown to still regulate cell proliferation (Miloloza et al., 2000) . This mutant was found to have no effects on cell size control. (3) High Putative serine/threonine protein kinase PRK (prk) U18420
Ras-related small GTP-binding protein Rab5 (rab5) U27655 RGP3 J05200
Ryanodine receptor U07361 Sorbitol dehydrogenase gene L21715
Troponin I fast-twitch isoform levels of Myc inhibit the antiproliferative effects of tuberin, but not tuberin's consequences on size regulation. In the past, cells overexpressing Myc or the TSC genes have been investigated in detail for the expression of CDK inhibitors and cyclins as well as for CDK activities. That Myc abrogates the antiproliferative effects of tuberin is interesting since both have been implicated in the regulation of the CDK inhibitor p27 (Soucek et al., 1998b; Miloloza et al., 2000 Miloloza et al., , 2002 Beier et al., 2000 and references therein) . Still, to clarify how Myc abrogates tuberin's cell cycle effects further investigations are necessary. At 48 h after transfection, TSC1 mRNA and GAPDH mRNA expression (a) and FKBP38 mRNA and GAPDH mRNA expression (b) were analysed by semiquantitative RT-PCR. PCR products were subjected to electrophoresis in 2% agarose gels, visualized by SYBR GREEN staining and quantified using a densitometric computer software (LabWorks image analysis software). The expression levels were normalized to GAPDH and expressed relative to the control, set as 1.0 (7standard deviations). The given numbers represent the average. (c) pcDNA3 vector, empty as negative control, or harboring either the TSC1 mutant 127 (containing amino acids 788-1153 of hamartin) or the TSC1 mutant 128 (containing amino acids 228-572 of hamartin) were transfected into logarithmically growing HeLa cells. At 48 h after transfection, FKBP38 mRNA and GAPDH mRNA expression was analysed by semiquantitative RT-PCR. PCR products were analysed as described above. (d) Mammalian expression vectors, empty as negative control, or harboring the dominantnegative mutant TSC2DRL, were transfected into logarithmically growing HeLa cells and the expression of FKBP38 mRNA and GAPDH mRNA was analysed as described above Although TSC2 has been demonstrated to be involved in transcriptional control Henry et al., 1998; Lou et al., 2001) , no microarray analysis of the effects of modulated TSC gene expression has been performed so far. To obtain more mechanistical insights into how TSC genes could mediate their cell size effects, we performed microarray analyses after overexpression of TSC1 or TSC2 in HeLa cells. Summarizing the results of TSC1 and TSC2 overexpressions revealed only 44 out of 2400 prespotted genes to be upregulated 4threefold and only 22 genes to be 4threefold downregulated. Upon these are very interesting genes and further investigations are warranted to study the role of the observed deregulations for the molecular development of TSC. We decided to further investigate the impact of the upregulation of FKBP38 for the cell size effects described here because (1) FKBPs, as TSC1 and TSC2, have been demonstrated to play a role in cell size control, (2) FKBPs, as TSC1 and TSC2, were demonstrated also to be involved in cell cycle regulation, (3) FKBP38, although expressed in all tissues, occurs with particularly high densities in the brain, which is interesting with respect to the brain-specific hamartomas, called tubers, of high clinical relevance for the phenotype of TSC. We found that in cells, in which upregulation of FKBP38 mRNA is blocked by antisense oligonucleotide treatment, the TSC genes cannot mediate cell size effects anymore. Another FKBP, FKBP12, is associated with mTOR and accordingly involved in the regulation of the insulin signaling pathway. In future, it would be of interest to test whether FKBP38 is also involved in this pathway, which would provide an explanation for our results that TSC gene-mediated cell size control is dependent on both, FKBP38 and PI3K/ Akt. Very recently, evidence has been provided that FKBP38 might function in the regulation of apoptosis by anchoring Bcl-2 to mitochondria (Shirane and Nakayama, 2003) . Since hamartoma growths must, to some extent, also escape the apoptotic control program of the human body, it is tempting to speculate that TSC genes could affect the control of apoptosis via regulation of FKBP38. Further experiments in this direction are planned in our laboratory.
Materials and methods

Cells, tissue culture and the PI3K inhibitor LY294002
HeLa cells (human cervical carcinoma cells) were obtained from the American Type Culture Collection (Manassas, VA). Rat1MycER cells express a protein containing the hormone binding domain of the human estrogen receptor fused to the 3 0 -end of human c-Myc (Eilers et al., 1989; Littlewood et al., 1995) . Growth and Myc induction with 100 nm 4-hydroxytamoxifen (4-OHT) was performed as described in Pusch et al. (1997) . All cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% calf serum and antibiotics (30 mg/l penicillin, 50 mg/l streptomycin sulfate). All cultures were kept at 371C and 7% CO 2 . The intracellular activity of PI3K was blocked by adding the inhibitor LY294002 (50 mm) (#9901; Cell Signaling Technology, Beverly, MA, USA) into the medium.
Transfections
For transfections, the following plasmids were used: the empty CMV-expression vector pcDNA3; pcDNA3 harboring fulllength human TSC1; pcDNA3 harboring full-length human TSC2; pcDNA3 harboring the TSC1 mutant 127 (containing amino acids 788-1153 cloned behind an N-terminal Xpress epitope tag) or the TSC1 mutant 128 (containing amino acids 228-572 cloned behind an N-terminal Xpress epitope tag) (used in Miloloza et al., 2000) ; the GFP-spectrin-expression vector described in Kalejta et al. (1997) ; the empty expression vector pSG5; pSG5 harboring full-length wild-type human TSC2; pSG5 harboring the TSC2 GAP-domain missense mutant 6 2/25 (C to G at nucleotide 4947 ¼ Asn to Lys at amino acid 1643); pSG5 harboring the TSC2 missense mutant 6 3/5 (A to G at nucleotide 4970 ¼ Asn to Ser at amino acid 1651) (used in Soucek et al., 2001) ; the CMV expression vector empty or harboring the dominant-negative TSC2DRL mutant (lacking the rabaptin-5-binding domain and the leucine zipper motifs) described in Pasumarthi et al. (2000) ; the Akt1 K179M pUSE dominant-negative mutant (Upstate, Lake Placid, NY, USA). Cell transfections were performed using the Lipofectamine Reagent obtained from Invitrogen (Life Technologies, 
Flow cytometry and proliferation assays
For cytofluorometric analyses of DNA distribution, cells were harvested by trypsinization and fixed by rapid submersion in ice-cold 85% ethanol. After overnight fixation at -201C, cells were pelleted and DNA was stained in 1 ml of staining solution (0.25 mg/ml propidium iodide, 0.05 mg/ml RNase, 0.1% Triton X-100 in citrate buffer, pH 7.8). GFP-positive cells were selectively gated and DNA distribution was analysed on a Beckton Dickinson FACScan (Beckton Dickinson, San Jose, CA, USA). To study the long-term effects of gene overexpression, selection for transfected cells was started 24 h after transfection. During the first 2 days of selection the G418 concentration was 700 mg/ml medium, thereafter the G418 concentration was set at 1500 mg/ml. Starting with equal cell numbers (harvesting and reseeding), the cell pools were kept under selection and cell numbers and cell size (see below) were determined at the indicated time points on the Casy Cell Counter and Analyser. For these analyses, cells growing in petri dishes were washed with buffer and harvested by trypsinization.
Cell size analyses
Simultaneous determination of particle concentrations and cell volume was performed using the CASY s Cell Counter and Analyser System, Model TTC (Scha¨rfe System, Reutlingen, Germany). Such measurements are based on the technology of pulse area analysis combined with the principles of resistance measurement. Therefore vital, nonfixed cells are suspended in an electrolyte buffer and aspirated through a measuring pore with defined size. While passing through, cells are scanned with high frequency in a low voltage field and are analysed for both cell count and cell volume. The pulse area of the resulting signal is strictly proportional to the volume of the particle generating the signal. Cell signals are then cumulated and assigned in a calibrated multi-channel analyser consisting of 512000 size channels. Size distribution of the sample analysed in this way is displayed graphically using 1024 size channels. Units for measurements of absolute cell volume are femtoliter. For more detailed information on this method see www.CASY-Technology.com. For these analyses logarithmically growing cells were harvested by trypsinization and cell pellets were resuspended in cold phosphate-buffered saline. Depending on the cell amount, about 10-200 ml of cell suspension were diluted in 10 ml of CASYton isotonic dilution buffer and 0.4 ml of total volume were then measured in triplets. Discrimination between vital and dead cells/cell debris was carried out by correct, cell-type-dependent cursor setting. The remaining cell suspension was fixed by rapid submersion in ice-cold 85% ethanol for FSC analysis of cell size and DNA distribution using a Becton Dickinson FACScan. To analyse samples for FSC distribution FSC parameters were collected using linear amplification mode. Data acquisition for subsequent FSC analysis was carried out by using CELLQUEST software. Flowcytometry data analysis tools to obtain relative cellular sizes from FSC data were CELLQUEST FSC histograms and histogram statistics. A total of 10 000-40 000 GFP-positive single cells were collected and the mean FSC-H of the transfected population was determined relative to the cell population transfected with the empty vector control. Therefore, FSC histogram overlays of the TSC overexpressing cell populations compared to the control populations were performed. Mean FSC values were then obtained by using CELLQUEST histogram statistic tools. Units used for calculating statistics were channel values.
Statistical analyses
Data are presented as the mean plus and minus the standard deviations. The significance of the observed differences was determined by Student's t-test (paired, two-tails) using Microsoft Excel. P-values 40.05 are defined as not significant.
Immunoblotting
Protein extracts were prepared in a buffer containing 20 mm HEPES, pH 7.9, 0.4 m NaCl, 2.5% glycerol, 1 mm EDTA, 1 mm phenylmethylsulfonylfluoride, 0.5 mm NaF, 0.5 mm Na 3 VO 4 , 0.02 mg/ml leupeptin, 0.02 mg/ml aprotinin, 0.003 mg/ ml benzamidinchloride, 0.1 mg/ml trypsin inhibitor and 0.5 mm DTT. Cells were lysed by freezing and thawing, the extracts were centrifuged and the supernatants were stored at À701C. Protein concentrations were determined using the Bio-Rad (Hercules, CA, USA) protein assay reagent with bovine serum albumin as the standard. Proteins were run on an SDSpolyacrylamide gel and transferred to nitrocellulose. Blots were stained with Ponceau-S to visualize the loaded protein.
Immunodetection was performed using the antihamartin antibodies 2197 and 2199 (Van Slegtenhorst et al., 1998) , the antituberin antibody 5063 (Wienecke et al., 1995) , the antituberin antibody C-20 (Santa Cruz, USA) or the anti-cmyc antibody 9E10 (Pharmingen, USA). To analyse the phosphorylation status of Akt, the Anti-Phospho-Akt (Ser473)-Antibody #9271 from Cell Signaling Technology (Beverly, MA, USA) was used. This antibody detects Akt only when phosphorylated at Ser473. Signals were detected using the enhanced chemiluminescence method (Amersham, Little Chalfont, UK).
Microarray analyses
Microarray analyses were performed to screen for genes with modulated expression in HeLa cells upon ectopic overexpression of TSC1 or TSC2. For these analyses the MICROMAX Human cDNA System I-Direct (Cat. No. MPS102) obtained from NEN Life Science (Perkin-Elmer Life Sciences, Boston, MA, USA) was used. Each of these array systems is prespotted with 2400 known human genes. For detailed information on the spotted gene sequences, see www.perkinelmer.com. HeLa cells were transfected with empty vector controls and vectors harboring TSC1 or TSC2. RNA preparation, cDNA synthesis and labeling (out of 100 mg RNA), and microarray hybridization were performed precisely following the protocol provided by the manufacturer (see again www.perkinelmer.com). Labeled cDNAs from cells transfected with the empty vector control and from TSC1-transfected cells were pooled together and simultaneously hybridized to a microarray in an overnight incubation. Pools of cDNAs obtained from an empty vector and TSC2-transfected cells were also hybridized. After hybridization the arrays were scanned and quantitative results were provided by the Custom Scanning and Data Processing Service of NEN (Perkin-Elmer). The results were exported to Excel for further analysis.
Quantitative RT-PCR
Primers for the specific detection of TSC1, FKBP38 and GAPDH were designed and synthesized by VBC-Genomics (Vienna, Austria). RNA was prepared as described above for microarray analyses. First-strand cDNA synthesis and semiquantitative PCR was performed using the rpRT-Mix from ViennaLab (Vienna, Austria) following the protocol provided by the manufacturer. Dilutions of cDNA concentrations were optimized to amplify the PCR products within the linear range. For quantitative analyses the cDNA concentrations estimated in this manner were used for PCR reactions at constant cycle numbers to simultaneously amplify products specific for TSC1, FKBP38 and GAPDH as control.
Antisense experiments
Antisense oligonucleotides have been designed and synthesized specifically for the modulation of FKBP38 expression by BIOGNOSTIK (Go¨ttingen, Germany) according to the NCBI gene accession number L37033. The used control oligonucleotide is of the same length with the same proportion of the four base pairs, but randomly organized. Phosphorothioate oligonucleotides were used to ensure sufficient stability against intracellular DNAses. According to the manufacturer's protocol, oligonucleotides were routinely used at a concentration of 2 mm. During the course of the experiments to overexpress TSC genes in antisense-treated cells, the constant presence of the oligonucleotides was proven by microscopically detecting fluorescence-labeled oligonucleotides.
